Unleashing a Lazarus Effect With Selpercatinib in a Never-Smoker Patient With Stage IV, Chemo-Immunotherapy Refractory, RET C630Y-Mutant, Small-Cell Lung Cancer: A First Case Report.
Antonio CallesMarta ArreguiJulia Suárez-GonzálezMaría García-MartosIvan Marquez-RodasRosa ÁlvarezMiguel MartinPublished in: JCO precision oncology (2023)